ChronoScale Corporation Common Stock (NASDAQ:CHRN) Share Price Passes Above 50 Day Moving Average – Time to Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $11.77 and traded as high as $16.29. ChronoScale Corporation Common Stock shares last traded at $15.90, with a volume of 415,920 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average target price of $6.00.

ChronoScale Corporation Common Stock Stock Down 2.6%

The company has a 50 day simple moving average of $11.82 and a two-hundred day simple moving average of $8.98. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $55.16 million, a P/E ratio of -2.88 and a beta of 0.86.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings data on Tuesday, April 28th. The company reported ($2.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($2.01). ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The company had revenue of $2.14 million for the quarter, compared to the consensus estimate of $4.29 million. As a group, equities analysts predict that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

Several hedge funds and other institutional investors have recently modified their holdings of the business. Roble Belko & Company Inc raised its holdings in shares of ChronoScale Corporation Common Stock by 104.5% in the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after buying an additional 1,195 shares during the period. Geode Capital Management LLC raised its holdings in shares of ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after buying an additional 10,281 shares during the period. Virtu Financial LLC purchased a new stake in shares of ChronoScale Corporation Common Stock in the third quarter worth approximately $57,000. Shay Capital LLC purchased a new stake in shares of ChronoScale Corporation Common Stock in the third quarter worth approximately $67,000. Finally, Citadel Advisors LLC purchased a new stake in shares of ChronoScale Corporation Common Stock in the third quarter worth approximately $198,000. 6.42% of the stock is currently owned by hedge funds and other institutional investors.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.